Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Mol Cancer Ther. 2017 Oct 27;17(1):50–59. doi: 10.1158/1535-7163.MCT-17-0173

Figure 5. Significant correlation of MLKL expression with susceptibilities of ovarian cancer cells to ceramide nanoliposomes-induced cell death.

Figure 5

A, Extracted cellular proteins from the indicated ovarian cancer cell lines were subjected to immunoblot analysis with antibodies for MLKL, RIPK-1, RIPK-3 and β-actin. Equal amounts of protein were loaded in each lane. Three independent experiments were performed and representative images are shown. The intensity of MLKL protein expression was quantified using Image Lab. IC50 values for ceramide nanoliposomes are plotted with MLKL protein expression (B), RIPK1 protein expression (C) and RIPK3 protein expression (D). R2 values were determined by GraphPad prism.